The Washington Post, January 5, 2011. Joshua M. Sharfstein, the second-in-command at the Food and Drug Administration, is leaving that post after less than two years to become Maryland’s top public health official, Gov. Martin O’Malley said Tuesday.
Read More »We’re In The News
As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.
Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.
Panel Votes to Expand Surgery for Less Obese
New York Times, December 3, 2010. A federal advisory panel Friday endorsed an expansion of the use of Allergan’s Lap-Band stomach-restricting device to patients who are less than severely obese. Where’s the long-term data?
Read More »Experts Endorse Obesity Surgery
The Washington Post, December 3, 2010. However, this worries NCHR President: “We do patients no favors when we sell them implanted medical products that have been tested on just a few patients for only one year.”
Read More »F.D.A. Rejects Qnexa, a Third Weight-Loss Drug
New York Times, October 29, 2010. FDA requested the company provide thorough evaluation of the drug’s potential for causing birth defects and heart problems.
Read More »Glaxo’s Avandia to Be Pulled From EU Market, Restricted in U.S.
Bloomberg, September 23, 2010. GlaxoSmithKline Plc‘s Avandia, once the world’s best-selling diabetes drug, will be withdrawn in Europe and restricted in the U.S. after a three-year review of the medicine’s heart risks.
Read More »